Preferred Label : Alipogene tiparvovec;

UNII : 20OK4AFR4Y;

Details


Keyword's position in hierarchy(ies) : arborescence

Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_2579395/fr/glybera
http://www.has-sante.fr/portail/jcms/c_2579395/fr/glybera-alipogene-tiparvovec-therapie-genique
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
alipogene tiparvovec
hyperlipoproteinemia type i
lipoprotein lipase
hyperlipoproteinemia type i
injections, intramuscular
adult
pancreatitis
genetic testing
genetic therapy
genetic vectors
dependovirus
guidelines for drug use
orphan drug production
rare diseases
familial lipoprotein lipase deficiency
Alipogene tiparvovec

---
https://www.ema.europa.eu/medicines/human/EPAR/Glybera
2012
false
United Kingdom
French
English
Alipogene tiparvovec
Alipogene tiparvovec
alipogene tiparvovec
orphan drug production
drug approval
europe
treatment outcome
adult
lipoprotein lipase
pancreatitis
hyperlipoproteinemia type i
injections, intramuscular
dependovirus
genetic vectors
cytogenetic analysis
hyperlipoproteinemia type i
summary of product characteristics
package leaflet
drug evaluation
syndication feed
continuity of patient care
aged
drug interactions
pregnancy
breast feeding
hyperlipoproteinemia type i
clinical trials as topic
drug evaluation, preclinical
genetic therapy
genetic therapy

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.